Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Frega

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Oncologist|November 4, 2016
In ReplyGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
Journal of Chemotherapy (Florence, Italy)|July 27, 2021
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysisRoberto Filippi, Francesco Leone, Lorenzo Fornaro, et al.
International Journal of Molecular Sciences|November 13, 2025
Establishment and Characterization of OS-MET-R-092: A Novel Patient-Derived Cell Culture from an Osteosarcoma Bone MetastasisVeronica Giusti, Leonardo Fantoni, Monica Torsello, et al.
Cancers|June 24, 2022
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative StudyEmanuela Palmerini, Laura Pazzaglia, Luca Cevolani, et al.
International Journal of Molecular Sciences|February 27, 2026
Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in ChondrosarcomaAgnieszka E Zając, Piotr Rutkowski, Anna Szumera-Ciećkiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Journal of Chemotherapy (Florence, Italy)|February 14, 2022
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancyMargherita Rimini, Andrea Casadei-Gardini, Giovanni Brandi, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Oncologist|November 4, 2016
In ReplyGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
Journal of Chemotherapy (Florence, Italy)|July 27, 2021
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysisRoberto Filippi, Francesco Leone, Lorenzo Fornaro, et al.
International Journal of Molecular Sciences|November 13, 2025
Establishment and Characterization of OS-MET-R-092: A Novel Patient-Derived Cell Culture from an Osteosarcoma Bone MetastasisVeronica Giusti, Leonardo Fantoni, Monica Torsello, et al.
Cancers|June 24, 2022
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative StudyEmanuela Palmerini, Laura Pazzaglia, Luca Cevolani, et al.
International Journal of Molecular Sciences|February 27, 2026
Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in ChondrosarcomaAgnieszka E Zając, Piotr Rutkowski, Anna Szumera-Ciećkiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Journal of Chemotherapy (Florence, Italy)|February 14, 2022
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancyMargherita Rimini, Andrea Casadei-Gardini, Giovanni Brandi, et al.
Pageof 6